China Health Group Inc.

HKEX:8225.HK

0.172 (HKD) • At close October 15, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 21.42513.0983.60183.06363.21659.60658.49120.24120.4975.95614.93128.68818.09937.68747.30839.18638.72957.05242.15736.15735.6832.453
Cost of Revenue 13.2137.34719.74416.1049.7517.242.0753.3574.983.05520.11216.23611.09416.31720.67423.80415.77124.76620.12117.397.2119.376
Gross Profit 8.2125.74363.85766.95953.46552.36656.41616.88415.5172.901-5.18112.4527.00521.3726.63415.38222.95832.28622.03618.76728.46923.077
Gross Profit Ratio 0.3830.4390.7640.8060.8460.8790.9650.8340.7570.487-0.3470.4340.3870.5670.5630.3930.5930.5660.5230.5190.7980.711
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 7.60613.97314.4333.66.0978.5325.1884.3925.37912.73720.917.44851.31462.59217.30447.54418.16517.54216.58511.8679.5693.621
Selling & Marketing Expenses 57.937000000000000000000000
SG&A 7.60613.97314.4333.66.0978.5325.1884.3925.37912.73720.917.44851.31462.59217.30447.54418.16517.54216.58511.8679.5693.621
Other Expenses 0.0047.8277.3378.28814.75116.14800-2.7310000000000.191000
Operating Expenses 66.54321.821.7711.88820.84824.6822.4514.00812.18641.36721.56113.77949.94340.36715.2435.22915.73217.54216.5857.2876.4753.527
Operating Income -57.327-15.80942.51855.37432.62627.73133.9742.8850.172-8.65-26.081-7.938-100.255-40.85911.527-19.8477.22620.3755.45111.4821.99419.55
Operating Income Ratio -2.676-1.2080.5090.6670.5160.4650.5810.1430.008-1.452-1.747-0.277-5.539-1.0840.244-0.5060.1870.3570.1290.3180.6160.602
Total Other Income Expenses Net -0.884-0.0170.00315.422-0.172-0.063-0.076-0.8-3.54852.767-4.88511.169-49.517-14.563-5.217-7.395-5.338-1.6020.952000
Income Before Tax -58.211-15.82642.52170.79632.45427.66833.8982.085-3.37644.117-30.9663.231-149.772-55.4226.31-27.2421.88818.7736.40311.4821.99419.55
Income Before Tax Ratio -2.717-1.2090.5090.8520.5130.4640.580.103-0.1657.407-2.0740.113-8.275-1.4710.133-0.6950.0490.3290.1520.3180.6160.602
Income Tax Expense -0.1970.0176.19610.1464.6624.5043.444-0.0420.1110.0320.0530.1134.0241.8380.277-9.930.7883.1750.8870.8811.5060.237
Net Income -58.014-15.84336.32560.6527.79223.16430.4542.127-3.35344.117-31.0283.118-153.796-56.9286.276-16.3541.59715.5635.64410.76720.23218.941
Net Income Ratio -2.708-1.210.4350.730.440.3890.5210.105-0.1647.407-2.0780.109-8.497-1.5110.133-0.4170.0410.2730.1340.2980.5670.584
EPS -0.058-0.0160.0370.0610.0280.0230.0310.002-0.0040.096-0.0850.006-0.28-0.10.012-0.0250.0030.0290.0110.020.0440.047
EPS Diluted -0.058-0.0160.0370.0610.0280.0230.0310.002-0.0040.096-0.0850.006-0.28-0.10.012-0.0250.0030.0280.010.020.0430.047
EBITDA -57.977-15.65842.71955.66533.89828.77534.9943.9171.814-7.496-24.2910.045-33.11-26.3315.516-15.20410.14421.6466.91311.94322.18819.864
EBITDA Ratio -2.706-1.1960.5110.670.5360.4830.5980.1940.089-1.259-1.6270.002-1.829-0.6990.328-0.3880.2620.3790.1640.330.6220.612